Business · 30/10/2000

FDA Revises Postmarketing Status Reports for Approved Human Drugs and Licensed Biological Products

The FDA is updating its requirements for annual reports on postmarketing studies for approved human medications and licensed biological products, and is mandating that applicants submit these reports for certain studies. This change aims to implement the Food and Drug Administration Modernization Act of 1997 (FDAMA).